Hollow microneedle assisted intradermal delivery of hypericin lipid nanocapsules with light enabled photodynamic therapy against skin cancer
Tekko, I. A.
Aly, R. G.
Vora, L. K.
Bell, S. J.
McCarthy, H. O.
Donnelly, R. F.
AffiliationSchool of Pharmacy, Queen's University Belfast,
MetadataShow full item record
AbstractPhotodynamic therapy (PDT) to manage non-melanoma skin cancers has garnered great attention over the past few years. Hypericin (Hy) is a potent lipid-soluble photosensitiser with promising anticancer therapeutic activities. Nevertheless, its poor water-solubility, aggregation in biological systems and insufficient skin penetration restricted its effective exploitation. Herein, we report for the first-time encapsulation of Hy into lipid nanocapsules (Hy-LNCs), and then application of an AdminPen™ hollow microneedles (Ho-MNs) array and an in-house fabricated Ho-MN to enable efficient intradermal delivery. The physicochemical properties, photoactivity, ex vivo drug distribution and cellular uptake were evaluated. Results showed that Hy-LNCs were successfully formed with a particle size of 47.76 ± 0.49 nm, PDI of 0.12 ± 0.02, high encapsulation efficiency (99.67% ± 0.35), 396 fold higher photoactivity, 7 fold higher skin drug deposition, significantly greater cellular uptake and higher photocytotoxicity compared to free Hy. The therapeutic effect of Hy-LNCs was finally assessed in vivo using a nude mouse model with transplanted tumours. Interestingly, Hy-LNCs delivered by Ho-MN exhibited remarkable anti-tumour destruction (85.84%) after irradiation with 595 nm. This study showed that Ho-MNs-driven delivery of Hy-LNCs followed by irradiation could form a promising minimally invasive, effective and site-specific approach for managing non-melanoma skin cancers.
CitationAbd-El-Azim H, Tekko IA, Ali A, Ramadan A, Nafee N, Khalafallah N, et al. Hollow microneedle assisted intradermal delivery of hypericin lipid nanocapsules with light enabled photodynamic therapy against skin cancer. Vol. 348, Journal of Controlled Release. Elsevier BV; 2022. p. 849–69.
JournalJournal of Controlled Release
- Hypericin-loaded lipid nanocapsules for photodynamic cancer therapy in vitro.
- Authors: Barras A, Boussekey L, Courtade E, Boukherroub R
- Issue date: 2013 Nov 7
- Hypericin-loaded oil-in-water nanoemulsion synthesized by ultrasonication process enhances photodynamic therapy efficiency.
- Authors: Ma HL, Varanda LC, Perussi JR, Carrilho E
- Issue date: 2021 Oct
- Hypericin encapsulated in solid lipid nanoparticles: phototoxicity and photodynamic efficiency.
- Authors: Lima AM, Pizzol CD, Monteiro FB, Creczynski-Pasa TB, Andrade GP, Ribeiro AO, Perussi JR
- Issue date: 2013 Aug 5
- Improved photodynamic effect through encapsulation of two photosensitizers in lipid nanocapsules.
- Authors: Barras A, Skandrani N, Gonzalez Pisfil M, Paryzhak S, Dumych T, Haustrate A, Héliot L, Gharbi T, Boulahdour H, Lehen'kyi V, Bilyy R, Szunerits S, Bidaux G, Boukherroub R
- Issue date: 2018 Oct 7
- Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of CDKN1A.
- Authors: Halaburková A, Jendželovský R, Kovaľ J, Herceg Z, Fedoročko P, Ghantous A
- Issue date: 2017